HARRIS ASSOCIATES L P – Regeneron Pharmaceuticals, Inc. Transaction History
HARRIS ASSOCIATES L P portfolio value:
$129.62M
portfolio value
HARRIS ASSOCIATES L P quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -67.70% | -394.45K shares | -214.77M | $688.87 | 188.17K |
| Q2 2022 | share | Decrease | -46.70% | -510.39K shares | -418.97M | $591.13 | 582.62K |
| Q1 2022 | share | Decrease | -17.28% | -228.30K shares | -71.05M | $698.42 | 1.09M |
| Q4 2021 | share | Decrease | -0.38% | -4.97K shares | 31.79M | $642.51 | 1.32M |
| Q3 2021 | share | Decrease | -8.22% | -118.75K shares | -4.47M | $605.18 | 1.32M |
| Q2 2021 | share | Increase | +39.81% | 411.47K shares | 318.09M | $558.54 | 1.44M |
| Q1 2021 | share | Increase | +95.71% | 505.44K shares | 233.88M | $473.14 | 1.03M |
| Q4 2020 | share | Decrease | -20.74% | -138.16K shares | -117.83M | $483.11 | 528.13K |
| Q3 2020 | share | Decrease | -45.71% | -560.92K shares | -392.37M | $559.78 | 666.29K |
| Q2 2020 | share | Decrease | -47.03% | -1.08M shares | -366.02M | $623.65 | 1.22M |
| Q1 2020 | share | Decrease | -46.94% | -2.04M shares | -508.28M | $488.29 | 2.31M |
| Q4 2019 | share | Increase | +5.44% | 225.39K shares | 490.82M | $375.48 | 4.36M |
| Q3 2019 | share | Increase | +5.79% | 226.73K shares | -76.46M | $277.4 | 4.14M |
| Q2 2019 | share | Increase | +46.79% | 1.24M shares | 130.19M | $313 | 3.91M |
| Q1 2019 | share | Decrease | -11.44% | -344.43K shares | -29.64M | $410.62 | 2.66M |
| Q4 2018 | share | Decrease | -5.11% | -162.23K shares | -157.51M | $373.5 | 3.01M |
| Q3 2018 | share | Increase | +0.79% | 24.96K shares | 196.01M | $404.04 | 3.17M |
| Q2 2018 | share | Increase | +85.21% | 1.44M shares | 500.83M | $344.99 | 3.14M |
| Q1 2018 | share | Increase | 0.00% | 1.70M shares | 585.42M | $344.36 | 1.70M |